Artwork

Content provided by MIT Sloan Management Review and Boston Consulting Group (BCG), MIT Sloan Management Review, and Boston Consulting Group (BCG). All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by MIT Sloan Management Review and Boston Consulting Group (BCG), MIT Sloan Management Review, and Boston Consulting Group (BCG) or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Training AI to Detect Disease: Stand Up To Cancer’s Julian Adams

31:40
 
Share
 

Manage episode 488053549 series 2803274
Content provided by MIT Sloan Management Review and Boston Consulting Group (BCG), MIT Sloan Management Review, and Boston Consulting Group (BCG). All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by MIT Sloan Management Review and Boston Consulting Group (BCG), MIT Sloan Management Review, and Boston Consulting Group (BCG) or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

Julian Adams tried but didn’t succeed at retirement after a productive career as a medical chemist with several U.S. Food and Drug Association approvals of cancer-related treatments, including cell therapy for bone marrow transplantation. Soon after, his participation in a Stand Up To Cancer advisory group led to his appointment as the nonprofit’s president and CEO.

The research organization raises money to advance the diagnosis of numerous cancers. Given rapid technological advancements, our podcast hosts were eager to invite Julian on the show to share how Stand Up To Cancer uses artificial intelligence to aid in this pursuit. Read the episode transcript here.

For more information on Stand Up To Cancer and how to donate to the organization, please visit this website.

Guest bio

Julian Adams, president and CEO of Stand Up To Cancer, is among the world’s foremost oncology researchers. He was previously CEO of biopharmaceutical company Gamida Cell and president of R&D at Infinity Pharmaceuticals, where he oversaw development of small molecule drugs to treat cancer. He has also held roles at Millennium Pharmaceuticals, Boehringer Ingelheim, LeukoSite, and ProScript.

Adams’s recognitions include the 2012 Warren Alpert Foundation Prize for his role in the discovery and development of bortezomib, an anti-cancer drug; the 2012 C. Chester Stock Award Lectureship from Memorial Sloan Kettering Cancer Center; and the 2001 Ribbon of Hope Award for Velcade from the International Myeloma Foundation. He holds more than 40 patents and has authored more than 130 papers and book chapters. He received his bachelor’s degree and an honorary doctor of science degree from McGill University and his Ph.D. from MIT in synthetic organic chemistry.

Me, Myself, and AI is a collaborative podcast from MIT Sloan Management Review and Boston Consulting Group and is hosted by Sam Ransbotham and Shervin Khodabandeh. Our engineer is David Lishansky, and the executive producer is Allison Ryder.

Stay in touch with us by joining our LinkedIn group, AI for Leaders at mitsmr.com/AIforLeaders or by following Me, Myself, and AI on LinkedIn.

We encourage you to rate and review our show. Your comments may be used in Me, Myself, and AI materials.

  continue reading

101 episodes

Artwork
iconShare
 
Manage episode 488053549 series 2803274
Content provided by MIT Sloan Management Review and Boston Consulting Group (BCG), MIT Sloan Management Review, and Boston Consulting Group (BCG). All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by MIT Sloan Management Review and Boston Consulting Group (BCG), MIT Sloan Management Review, and Boston Consulting Group (BCG) or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

Julian Adams tried but didn’t succeed at retirement after a productive career as a medical chemist with several U.S. Food and Drug Association approvals of cancer-related treatments, including cell therapy for bone marrow transplantation. Soon after, his participation in a Stand Up To Cancer advisory group led to his appointment as the nonprofit’s president and CEO.

The research organization raises money to advance the diagnosis of numerous cancers. Given rapid technological advancements, our podcast hosts were eager to invite Julian on the show to share how Stand Up To Cancer uses artificial intelligence to aid in this pursuit. Read the episode transcript here.

For more information on Stand Up To Cancer and how to donate to the organization, please visit this website.

Guest bio

Julian Adams, president and CEO of Stand Up To Cancer, is among the world’s foremost oncology researchers. He was previously CEO of biopharmaceutical company Gamida Cell and president of R&D at Infinity Pharmaceuticals, where he oversaw development of small molecule drugs to treat cancer. He has also held roles at Millennium Pharmaceuticals, Boehringer Ingelheim, LeukoSite, and ProScript.

Adams’s recognitions include the 2012 Warren Alpert Foundation Prize for his role in the discovery and development of bortezomib, an anti-cancer drug; the 2012 C. Chester Stock Award Lectureship from Memorial Sloan Kettering Cancer Center; and the 2001 Ribbon of Hope Award for Velcade from the International Myeloma Foundation. He holds more than 40 patents and has authored more than 130 papers and book chapters. He received his bachelor’s degree and an honorary doctor of science degree from McGill University and his Ph.D. from MIT in synthetic organic chemistry.

Me, Myself, and AI is a collaborative podcast from MIT Sloan Management Review and Boston Consulting Group and is hosted by Sam Ransbotham and Shervin Khodabandeh. Our engineer is David Lishansky, and the executive producer is Allison Ryder.

Stay in touch with us by joining our LinkedIn group, AI for Leaders at mitsmr.com/AIforLeaders or by following Me, Myself, and AI on LinkedIn.

We encourage you to rate and review our show. Your comments may be used in Me, Myself, and AI materials.

  continue reading

101 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play